TY - JOUR
T1 - Relationship between survivorship care plans and unmet information needs, quality of life, satisfaction with care, and propensity to engage with, and attend, follow-up care
AU - Hill, Rebecca E.
AU - Mercieca-Bebber, Rebecca
AU - Fardell, Joanna E.
AU - Wakefield, Claire E.
AU - Signorelli, Christina
AU - Webber, Kate
AU - Cohn, Richard J.
N1 - Funding Information:
We recruited survivors of adult cancer via two online databases (Register4: www.register4.org.au ; PathFinder: www.pathfinderregister.com.au ). Register4 has 38,758 members aged between 20 and 96 years from across Australia (96.6% being female because it was seed funded by the National Breast Cancer Foundation). PathFinder is composed of 650 men interested in prostate cancer research. Register4 and PathFinder each emailed an invitation to their members, and one reminder, between April and November 2018. They also advertised our survey on their websites. 19
Funding Information:
Rebecca E. Hill is supported by an Australian Government Research Training Program scholarship. Joanna E. Fardell is a Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group Senior Research Fellow and is supported by a Cancer Institute NSW Research Capacity Building grant (2021/CBG003). Claire E. Wakefield is supported by the National Health and Medical Research Council (NHMRC) of Australia (APP1143767). Rebecca Mercieca‐Bebber is supported by an Early Career Fellowship from the NHMRC (APP1138100). Christina Signorelli is supported by an Early Career Fellowship from the Cancer Institute NSW (2020/ECF1144). The Behavioural Sciences Unit’s survivorship research program is funded by the Kids’ Cancer Project and a Cancer Council NSW program grant (PG16‐02) with the support of the estate of the late Harry McPaul.
Publisher Copyright:
© 2023 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.
PY - 2023/12/1
Y1 - 2023/12/1
N2 - Background: The impact of survivorship care plans (SCPs) on the proximal and distal outcomes of adult and childhood cancer survivors, and parent proxies, is unclear. This study aimed to determine the relationship between SCP receipt and these outcomes. Methods: A cross-sectional survey of adult and childhood cancer survivors (and parent proxies for survivors aged younger than 16 years) across Australia and New Zealand was conducted. Multivariate regression models were fitted to measure the impact of SCP receipt on proximal (unmet information needs and propensity to engage with, and attend, cancer-related follow-up care) and distal outcomes (quality of life and satisfaction with cancer-related follow-up care) with control for cancer history and sociodemographic factors. Results: Of 1123 respondents, 499 were adult cancer survivors and 624 were childhood cancer survivors (including 222 parent proxies). We found that SCP receipt was predictive of greater attendance at, and awareness of, cancer-related follow-up care (adult: odds ratio [OR], 2.46; 95% CI, 1.18–5.12; OR, 2.38; 95% CI, 1.07–5.29; child/parent: OR, 2.61; 95% CI, 1.63–4.17; OR, 1.63; 95% CI, 1.06–2.50; respectively). SCP receipt also predicted fewer unmet information needs related to “follow-up care required” and “possible late effects” (adult: OR, 0.44; 95% CI, 0.20–0.96; OR, 0.29; 95% CI, 0.13–0.64; child/parent: OR, 0.46; 95% CI, 0.30–0.72; OR, 0.57; 95% CI, 0.38–0.85; respectively). In terms of distal outcomes, SCP receipt predicted a better global quality of life for adult cancer survivors (β, 0.08; 95% CI, −0.01–7.93), proxy-reported health-related quality of life (β, 0.15; 95% CI, 0.44–7.12), and satisfaction with follow-up care for childhood cancer survivors (OR, 2.93; 95% CI, 1.64–5.23). Conclusions: Previous studies have shown little impact of SCPs on distal end points. Results suggest that SCPs may be beneficial to cancer survivors’ proximal and distal outcomes.
AB - Background: The impact of survivorship care plans (SCPs) on the proximal and distal outcomes of adult and childhood cancer survivors, and parent proxies, is unclear. This study aimed to determine the relationship between SCP receipt and these outcomes. Methods: A cross-sectional survey of adult and childhood cancer survivors (and parent proxies for survivors aged younger than 16 years) across Australia and New Zealand was conducted. Multivariate regression models were fitted to measure the impact of SCP receipt on proximal (unmet information needs and propensity to engage with, and attend, cancer-related follow-up care) and distal outcomes (quality of life and satisfaction with cancer-related follow-up care) with control for cancer history and sociodemographic factors. Results: Of 1123 respondents, 499 were adult cancer survivors and 624 were childhood cancer survivors (including 222 parent proxies). We found that SCP receipt was predictive of greater attendance at, and awareness of, cancer-related follow-up care (adult: odds ratio [OR], 2.46; 95% CI, 1.18–5.12; OR, 2.38; 95% CI, 1.07–5.29; child/parent: OR, 2.61; 95% CI, 1.63–4.17; OR, 1.63; 95% CI, 1.06–2.50; respectively). SCP receipt also predicted fewer unmet information needs related to “follow-up care required” and “possible late effects” (adult: OR, 0.44; 95% CI, 0.20–0.96; OR, 0.29; 95% CI, 0.13–0.64; child/parent: OR, 0.46; 95% CI, 0.30–0.72; OR, 0.57; 95% CI, 0.38–0.85; respectively). In terms of distal outcomes, SCP receipt predicted a better global quality of life for adult cancer survivors (β, 0.08; 95% CI, −0.01–7.93), proxy-reported health-related quality of life (β, 0.15; 95% CI, 0.44–7.12), and satisfaction with follow-up care for childhood cancer survivors (OR, 2.93; 95% CI, 1.64–5.23). Conclusions: Previous studies have shown little impact of SCPs on distal end points. Results suggest that SCPs may be beneficial to cancer survivors’ proximal and distal outcomes.
KW - adult cancer
KW - childhood cancer
KW - quality of life
KW - survivorship
KW - survivorship care plan
KW - unmet needs
UR - http://www.scopus.com/inward/record.url?scp=85167703605&partnerID=8YFLogxK
U2 - 10.1002/cncr.34984
DO - 10.1002/cncr.34984
M3 - Article
C2 - 37566341
AN - SCOPUS:85167703605
SN - 0008-543X
VL - 129
SP - 3820
EP - 3832
JO - Cancer
JF - Cancer
IS - 23
ER -